Archive - January 2021
J&J’s one-dose COVID-19 vaccine proves 66% effective in phase 3 trial
Unprecedented Import-Alert Highlights Hand Sanitizer Risks
EU may restrict exports of some COVID-19 vaccines
The UK reasserts that the AZ vaccine is ‘effective across all age groups’
Think fast, be different: succeeding at speed chess in 2021’s COVID-19 world
UK trial of Novavax COVID-19 vaccine demonstrates 89.3% efficacy
EMA begins review of GBT’s sickle cell treatment Oxbryta
Valneva completes recruitment for Phase I/II COVID-19 vaccine study